A tale of two fibrillations.
Chen
Peng-Sheng
PS
Division of Cardiology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, Calif, USA. chenp@cshs.org
Wu
Tsu-Juey
TJ
Ting
Chih-Tai
CT
Karagueuzian
Hrayr S
HS
Garfinkel
Alan
A
Lin
Shien-Fong
SF
Weiss
James N
JN
D000200:Action Potentials; D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000633:toxicity; D016757:Death, Sudden, Cardiac / Q000209:etiology; D004562:Electrocardiography; D005711:Gallopamil / Q000494:pharmacology / Q000633:toxicity; D006329:Heart Conduction System / Q000187:drug effects / Q000503:physiopathology*; D006801:Humans; D008954:Models, Biological; D017202:Myocardial Ischemia / Q000503:physiopathology; D011817:Rabbits; D026941:Sodium Channel Blockers / Q000494:pharmacology / Q000633:toxicity; D017180:Tachycardia, Ventricular / Q000139:chemically induced / Q000503:physiopathology; D013779:Tetrodotoxin / Q000494:pharmacology / Q000633:toxicity; D014693:Ventricular Fibrillation / Q000145:classification* / Q000150:complications / Q000503:physiopathology
D002121:Calcium Channel Blockers; D026941:Sodium Channel Blockers; D005711:Gallopamil; D013779:Tetrodotoxin